MedPath

Succinylcholine

Generic Name
Succinylcholine
Brand Names
Anectine, Quelicin
Drug Type
Small Molecule
Chemical Formula
C14H30N2O4
CAS Number
306-40-1
Unique Ingredient Identifier
J2R869A8YF
Background

Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.

Indication

Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions
-
Associated Therapies
Tracheal Intubation

Muscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy

Not Applicable
Not yet recruiting
Conditions
Anesthesia
Bronchoscopy
Muscle Relaxants
Interventions
First Posted Date
2024-11-29
Last Posted Date
2024-11-29
Lead Sponsor
Peng Liang
Target Recruit Count
240
Registration Number
NCT06709066

High-Resolution Solid-State Manometry of the Effect of Succinylcholine on Barrier Pressure

Phase 4
Completed
Conditions
the Effect of Succinylcholine on Barrier Pressure
Interventions
First Posted Date
2022-09-27
Last Posted Date
2022-09-27
Lead Sponsor
China-Japan Friendship Hospital
Target Recruit Count
14
Registration Number
NCT05556408

Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg

Phase 4
Completed
Conditions
Intubation Conditions
Interventions
First Posted Date
2021-05-03
Last Posted Date
2024-03-19
Lead Sponsor
Matias Vested
Target Recruit Count
102
Registration Number
NCT04868409
Locations
🇩🇰

Bispebjerg Hospital, Copenhagen, Denmark

🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇩🇰

Department of Anaesthesiology, Pain and Respiratory Support, Rigshospitalet Glostrup, Glostrup, Denmark

and more 1 locations

Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery

Not Applicable
Conditions
Atelectasis
Tumor of Lung Parenchyma
Complication of Ventilation Therapy
Interventions
First Posted Date
2018-03-19
Last Posted Date
2018-03-20
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
30
Registration Number
NCT03469323
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

Completed
Conditions
Neuromuscular Blockade
Interventions
First Posted Date
2016-09-26
Last Posted Date
2019-09-12
Lead Sponsor
Jakob Louis Thomsen
Target Recruit Count
30430
Registration Number
NCT02914119
Locations
🇩🇰

Herlev Hospital, Herlev, Denmark

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

First Posted Date
2016-07-04
Last Posted Date
2023-05-23
Lead Sponsor
Rennes University Hospital
Target Recruit Count
351
Registration Number
NCT02822144
Locations
🇫🇷

Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes, Rennes, France

🇫🇷

Service d'anesthésie-réanimation - Fondation A. de Rothschild, Paris, France

🇫🇷

Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest, Brest, France

and more 1 locations

Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression

Not Applicable
Completed
Conditions
Depression
Interventions
First Posted Date
2016-01-28
Last Posted Date
2016-01-28
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
110
Registration Number
NCT02667353

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

Phase 4
Completed
Conditions
Neuromuscular Blockade
Postoperative Complications
Interventions
First Posted Date
2015-12-21
Last Posted Date
2018-07-17
Lead Sponsor
University of Chicago
Target Recruit Count
100
Registration Number
NCT02635542
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

Fade Upon TOF Stimulation Induced by Succinylcholine

Phase 4
Completed
Conditions
Muscle Relaxants
Interventions
First Posted Date
2015-04-24
Last Posted Date
2018-01-02
Lead Sponsor
University of Toledo Health Science Campus
Target Recruit Count
19
Registration Number
NCT02425449
Locations
🇺🇸

University of Toledo, Health Science Campus, Toledo, Ohio, United States

Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)

Phase 4
Withdrawn
Conditions
Neuromuscular Blockade
Interventions
First Posted Date
2015-04-07
Last Posted Date
2015-07-13
Lead Sponsor
Merck Sharp & Dohme LLC
Registration Number
NCT02410590
© Copyright 2025. All Rights Reserved by MedPath